Document is current
Any future updates will be listed below
-
Authors
Maric, Marija https://orcid.org/0000-0001-7780-0442
Segura-Bayona, Sandra https://orcid.org/0000-0001-7788-9889
Kuthethur, Raviprasad https://orcid.org/0000-0003-0697-7835
Takaki, Tohru
Borel, Valerie
Stanage, Tyler H. https://orcid.org/0000-0003-1668-9909
Ivanov, Miroslav P. https://orcid.org/0000-0001-9352-0969
Parnandi, Nishita
Hewitt, Graeme
Millar, Rhona
Fonseca, Carmen S.
Patel, Harshil https://orcid.org/0000-0003-2707-7940
Llorian, Miriam https://orcid.org/0000-0003-2582-6602
Warchal, Scott
Howell, Michael https://orcid.org/0000-0003-0912-0079
Chaudhuri, Arnab Ray
Kotsantis, Panagiotis https://orcid.org/0000-0002-6131-4009
Boulton, Simon J. https://orcid.org/0000-0001-6936-6834
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 18 August 2025
First Online: 26 September 2025
Competing interests
: S.J.B. and M.M. are inventors on a patent WO 2023/047123 (“Method for determining the suitability of an EXO1 inhibitor for the treatment of cancer”). S.J.B. is also co-founder, VP Science Strategy and shareholder at Artios Pharma Ltd. The other authors declare no competing interests.
